Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04414085
Other study ID # 0183-15-ASF
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 15, 2015
Est. completion date May 15, 2020

Study information

Verified date May 2020
Source Assaf-Harofeh Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

data from charts regarding clinical characteristics and androgens levels from first to last visit were collected


Description:

data from charts regarding clinical characteristics and androgens levels from first to last visit were collected Female patients only ages 10-18 years who were referred to the combined gynecology endocrinology adolescents clinic


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date May 15, 2020
Est. primary completion date May 15, 2020
Accepts healthy volunteers No
Gender Female
Age group 10 Years to 18 Years
Eligibility Inclusion Criteria:

age 10-18 years referred to gynecology endocrinology adolescents clinic

Exclusion Criteria:

no data available in chart no blood work available

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Israel Assaf Harofeh Medical Center Zerifin

Sponsors (1)

Lead Sponsor Collaborator
Assaf Harofeh MC

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Presence of hyperandrogenism signs (1 to 3 categorized) hirsuitism, acne, menses, each marked as 0 or 1 (none or present) 3 years
See also
  Status Clinical Trial Phase
Recruiting NCT04220437 - Identification of Neoatherosclerosis in ISR Patients Based on Artifical Intelligence